Prognostic Stage IV Breast Cancer AJCC v8 Withdrawn Phase 1 / 2 Trials for Copanlisib (DB12483)

IndicationStatusPhase
DBCOND0109667 (Prognostic Stage IV Breast Cancer AJCC v8)Withdrawn1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03803761A Study of a New Drug Combination, Copanlisib and Fulvestrant, in Advanced Breast CancerTreatment